Showing results (101-110 of 640) with videos related to
Sort By:
Pageof 64
Plos One|April 18, 2012
Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effectsTae Heung Kang, Chih-Ping Mao, Liangmei He, et al.Cancer Research|January 25, 2005
Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potencyTae Woo Kim, Jin-Hyup Lee, Liangmei He, et al.Oncoimmunology|September 18, 2018
Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrins-mediated CD8+ T cell infiltration to control mucosal tumor growthJin Qiu, Shiwen Peng, Andrew Yang, et al.Plos One|July 21, 2012
Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk geneChien-Fu Hung, An Jen Chiang, Hsiao-Hsuan Tsai, et al.Oncotarget|August 31, 2015
Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancerChao-Chih Wu, Yuh-Cheng Yang, Yun-Ting Hsu, et al.Plos One|March 26, 2014
Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumorsRuey-Shyang Soong, Liwen Song, Janson Trieu, et al.Vaccine|July 23, 2009
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun deliverySimon R Best, Shiwen Peng, Chi-Mou Juang, et al.Cell & Bioscience|March 8, 2016
Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvantMing-Chieh Yang, Andrew Yang, Jin Qiu, et al.Cancer Immunology, Immunotherapy : CII|April 26, 2013
Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effectsSung Yong Lee, Tae Heung Kang, Jayne Knoff, et al.Journal for Immunotherapy of Cancer|April 23, 2022
Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunitySsu-Hsueh Tseng, Max A Cheng, Emily Farmer, et al.Pageof 64